Burning Rock Biotech Ltd reports results for the quarter ended in December - Earnings Summary

Burning Rock Biotech

22/03/2022 13:30

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted
loss of CNY2.40​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of CNY1.69 per share.
    * Revenue rose 11.9% to CNY147.35 million from a year ago; 
analysts expected CNY136.50 million. 
    * Burning Rock Biotech Ltd's reported EPS for the quarter
was a
loss of CNY2.40​.
    * The mean earnings estimate of analysts had risen by
about 1.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Burning Rock Biotech Ltd shares had fallen by 7.2% this
quarter.
    * The company reported a quarterly loss of CNY251.14
million.
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $24.08 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 22 at 01:30 p.m.  ​All
figures in Chinese yuan renminbi unless otherwise stated